Literature DB >> 2822732

Cyclic activity of the receptors of cobalamin bound to transcobalamin II.

C A Hall1, P D Colligan, J A Begley.   

Abstract

The activity of receptors specific for human transcobalamin II-Cobalamin (TC II-Cbl) were measured in virus-transformed lymphoblasts, hepatocytes (hepatoma) and diploid fibro lasts. In all three types of human cells the receptor activity increased as cells went from a resting phase to the most actively dividing phase. Receptor activity declined as cell division slowed. The changes in activity of lymphoblasts and hepatocytes were produced by changes in receptor number and not by changes in affinity between receptors and TC II-Cbl. The basis of the change in fibroblasts was not clear. The Cbl-dependent methionine synthetase activity of fibroblasts, in contrast, tended to be greatest when the cultures were confluent and replication had slowed. As the fibroblasts became senescent the receptor activity for TC II-Cbl declined and the fluctuations with the phase of the cell were blunted. However, the release of apo TC II from the cells was maintained. These observations must be taken into consideration when the respective cells are used as models. Even more important are the implications of the observations of the changes in receptor activity for TC II-Cbl for the regulation of the entry of Cbl into cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822732     DOI: 10.1002/jcp.1041330125

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

Review 1.  B12 binding proteins.

Authors:  G Neale
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

2.  Down-regulation of transcobalamin receptor TCblR/CD320 by siRNA inhibits cobalamin uptake and proliferation of cells in culture.

Authors:  Shao-Chiang Lai; Yasumi Nakayama; Jeffrey M Sequeira; Edward V Quadros
Journal:  Exp Cell Res       Date:  2011-03-04       Impact factor: 3.905

3.  Characterization of the promoter region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin.

Authors:  Wenxia Jiang; Jeffrey M Sequeira; Yasumi Nakayama; Shao-Chiang Lai; Edward V Quadros
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

Review 4.  Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor.

Authors:  Edward V Quadros; Jeffrey M Sequeira
Journal:  Biochimie       Date:  2013-02-14       Impact factor: 4.079

5.  Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  Mol Cancer Ther       Date:  2010-09-21       Impact factor: 6.261

6.  Imaging Cobalamin Uptake within Malignant Breast Tumors In Vivo.

Authors:  Douglas A Collins
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

7.  Plasma membrane delivery, endocytosis and turnover of transcobalamin receptor in polarized human intestinal epithelial cells.

Authors:  Santanu Bose; Seema Kalra; Raghunatha R Yammani; Rajiv Ahuja; Bellur Seetharam
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

8.  Immunohistochemical quantification of the cobalamin transport protein, cell surface receptor and Ki-67 in naturally occurring canine and feline malignant tumors and in adjacent normal tissues.

Authors:  Annette M Sysel; Victor E Valli; Joseph A Bauer
Journal:  Oncotarget       Date:  2015-02-10

9.  Saporin Conjugated Monoclonal Antibody to the Transcobalamin Receptor TCblR/CD320 Is Effective in Targeting and Destroying Cancer Cells.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  J Cancer Ther       Date:  2013-07-22

10.  Intracellular and Tissue Levels of Vitamin B12 in Hepatocytes Are Modulated by CD320 Receptor and TCN2 Transporter.

Authors:  Joseph Boachie; Antonysunil Adaikalakoteswari; Ilona Goljan; Jinous Samavat; Felino R Cagampang; Ponnusamy Saravanan
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.